Rapport Therapeutics, Inc.RAPP stock score: 32/100

$23.59 · +0.81% · Scored Nov 19, 2026

Technical
26
Fundamental
33
News
51

The reading

Rapport Therapeutics (RAPP) scores 32 out of 100, which reads bearish, higher than 6% of Healthcare stocks and 7% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 33, technicals 26.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while EV/Revenue at 0 weighs the most against it.

On the daily chart, trend-following indicators average 17 and contrarian oscillators 61 — a split worth reading before trusting the technical total.

News sentiment is neutral at 51; it is shown, not counted in the composite.

Since Aug 23, 2026 the composite has ranged from 30 to 51, and it is down 19 points over the period.

About Rapport Therapeutics

Rapport Therapeutics (RAPP) is a clinical-stage biotechnology company developing drugs for central nervous system disorders. Its approach targets receptor-associated proteins, which help direct how receptors work in specific parts of the brain, with the aim of treating disease while limiting side effects seen with broader-acting drugs. Its lead candidate, RAP-219, is designed to act on AMPA receptors linked to a protein found mainly in brain regions where focal seizures start. RAP-219 is in late-stage trials as an add-on treatment for adults with focal onset seizures, and the company is also studying it in generalized tonic-clonic seizures, bipolar mania and a long-acting injectable form. Rapport has licensed rights to RAP-219 in China to a regional partner. It has no product sales and funds research with cash raised from investors.

In epilepsy, Rapport would compete with established anti-seizure medicines and newer entrants such as SK Biopharmaceuticals’ Xcopri, as well as with candidates from Xenon Pharmaceuticals and other developers. Its edge rests on a precision target that may reduce side effects, a long half-life that may allow simpler dosing and a platform for finding additional neuroscience candidates. Investors who follow RAPP stock tend to watch enrollment and results from the late-stage seizure trials. Data from other indications and long-term safety studies are closely followed. Cash runway, partnering activity and earlier pipeline progress are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward RAPP’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

33

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

  • EV/Revenue compares the whole company's value, debt included, with its sales.

  • Price-to-Sales ratio compares market capitalization to annual revenue.

  • Operating margins measure profitability after operating expenses.

29 weighted scorers; 10 had no data today and are left out rather than counted as zero.

Technical · daily

23

Pulling it up

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Bollinger Bands (20-period) plot standard deviations above and below a moving average.

  • Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

Holding it back

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • SMA 50 Trend evaluates the slope of the 50-period moving average.

  • Simple Moving Average (200-period) is the most widely followed long-term trend indicator.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
51

Technical score by timeframe

ChartScoreWeight
Hourly371
Daily233
Weekly252

Composite score, last 90 days

05010032Aug 23, 2026Nov 19, 2026Aug 23, 2026: 51Aug 24, 2026: 51Aug 25, 2026: 51Aug 26, 2026: 51Aug 27, 2026: 50Aug 28, 2026: 48Aug 29, 2026: 49Aug 30, 2026: 49Aug 31, 2026: 49Sep 1, 2026: 50Sep 2, 2026: 50Sep 4, 2026: 48Sep 5, 2026: 47Sep 6, 2026: 47Sep 7, 2026: 47Sep 8, 2026: 48Sep 9, 2026: 45Sep 10, 2026: 45Sep 11, 2026: 46Sep 12, 2026: 46Sep 13, 2026: 46Sep 14, 2026: 46Sep 15, 2026: 45Sep 16, 2026: 43Sep 17, 2026: 44Sep 18, 2026: 43Sep 19, 2026: 43Sep 20, 2026: 43Sep 21, 2026: 42Sep 22, 2026: 44Sep 23, 2026: 41Sep 24, 2026: 39Sep 25, 2026: 38Sep 26, 2026: 38Sep 27, 2026: 38Sep 28, 2026: 38Sep 29, 2026: 37Sep 30, 2026: 38Oct 1, 2026: 37Oct 2, 2026: 37Oct 3, 2026: 36Oct 4, 2026: 36Oct 5, 2026: 38Oct 6, 2026: 37Oct 7, 2026: 36Oct 8, 2026: 36Oct 9, 2026: 37Oct 10, 2026: 37Oct 11, 2026: 37Oct 12, 2026: 36Oct 13, 2026: 36Oct 14, 2026: 35Oct 15, 2026: 37Oct 16, 2026: 34Oct 17, 2026: 34Oct 18, 2026: 34Oct 19, 2026: 36Oct 20, 2026: 36Oct 21, 2026: 34Oct 22, 2026: 34Oct 23, 2026: 33Oct 24, 2026: 34Oct 25, 2026: 34Oct 26, 2026: 33Oct 27, 2026: 32Oct 28, 2026: 30Oct 29, 2026: 32Oct 30, 2026: 33Nov 1, 2026: 34Nov 2, 2026: 33Nov 3, 2026: 34Nov 4, 2026: 35Nov 5, 2026: 32Nov 6, 2026: 32Nov 7, 2026: 32Nov 10, 2026: 36Nov 11, 2026: 38Nov 12, 2026: 31Nov 13, 2026: 34Nov 14, 2026: 34Nov 15, 2026: 34Nov 16, 2026: 33Nov 17, 2026: 32Nov 18, 2026: 32Nov 19, 2026: 32
Show the daily numbers
DateComposite
Nov 19, 202632
Nov 18, 202632
Nov 17, 202632
Nov 16, 202633
Nov 15, 202634
Nov 14, 202634
Nov 13, 202634
Nov 12, 202631
Nov 11, 202638
Nov 10, 202636
Nov 7, 202632
Nov 6, 202632
Nov 5, 202632
Nov 4, 202635
Nov 3, 202634
Nov 2, 202633
Nov 1, 202634
Oct 30, 202633
Oct 29, 202632
Oct 28, 202630
Oct 27, 202632
Oct 26, 202633
Oct 25, 202634
Oct 24, 202634
Oct 23, 202633
Oct 22, 202634
Oct 21, 202634
Oct 20, 202636
Oct 19, 202636
Oct 18, 202634
Oct 17, 202634
Oct 16, 202634
Oct 15, 202637
Oct 14, 202635
Oct 13, 202636
Oct 12, 202636
Oct 11, 202637
Oct 10, 202637
Oct 9, 202637
Oct 8, 202636
Oct 7, 202636
Oct 6, 202637
Oct 5, 202638
Oct 4, 202636
Oct 3, 202636
Oct 2, 202637
Oct 1, 202637
Sep 30, 202638
Sep 29, 202637
Sep 28, 202638
Sep 27, 202638
Sep 26, 202638
Sep 25, 202638
Sep 24, 202639
Sep 23, 202641
Sep 22, 202644
Sep 21, 202642
Sep 20, 202643
Sep 19, 202643
Sep 18, 202643
Sep 17, 202644
Sep 16, 202643
Sep 15, 202645
Sep 14, 202646
Sep 13, 202646
Sep 12, 202646
Sep 11, 202646
Sep 10, 202645
Sep 9, 202645
Sep 8, 202648
Sep 7, 202647
Sep 6, 202647
Sep 5, 202647
Sep 4, 202648
Sep 2, 202650
Sep 1, 202650
Aug 31, 202649
Aug 30, 202649
Aug 29, 202649
Aug 28, 202648
Aug 27, 202650
Aug 26, 202651
Aug 25, 202651
Aug 24, 202651
Aug 23, 202651

Key facts

Market cap
$1.4B
Sector
Healthcare
Industry
Biotechnology
Beta
1.40
Risk grade (1–10)
7
Next earnings
Nov 4, 2026

Questions

What is RAPP's stock rating today?

RAPP scores 32/100 (Bearish) as of Nov 19, 2026: technical 26, fundamental 33, and news sentiment 51, which is shown but not counted. Scores are recomputed every night.

What does Rapport Therapeutics do?

Rapport Therapeutics (RAPP) is a clinical-stage biotechnology company developing drugs for central nervous system disorders. Its approach targets receptor-associated proteins, which help direct how receptors work in specific parts of the brain, with the aim of treating disease while limiting side effects seen with broader-acting drugs.

Is RAPP stock a buy?

The score is not a buy or sell recommendation. A 32 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the RAPP score calculated?

91 weighted scorers feed it today: 29 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 3 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

RAPP stock score

HTML

<a href="https://stocksscores.com/stocks/rapp/"><img src="https://stocksscores.com/stocks/rapp/badge.svg" alt="RAPP stock score" height="20"></a>

Markdown

[![RAPP stock score](https://stocksscores.com/stocks/rapp/badge.svg)](https://stocksscores.com/stocks/rapp/)